Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Exploring the benefits and challenges of AI-driven large language models in gastroenterology: Think out of the box

J. Kral, M. Hradis, M. Buzga, L. Kunovsky

. 2024 ; 168 (4) : 277-283. [pub] 20240904

Language English Country Czech Republic

Document type Journal Article, Review

Artificial Intelligence (AI) has evolved significantly over the past decades, from its early concepts in the 1950s to the present era of deep learning and natural language processing. Advanced large language models (LLMs), such as Chatbot Generative Pre-Trained Transformer (ChatGPT) is trained to generate human-like text responses. This technology has the potential to revolutionize various aspects of gastroenterology, including diagnosis, treatment, education, and decision-making support. The benefits of using LLMs in gastroenterology could include accelerating diagnosis and treatment, providing personalized care, enhancing education and training, assisting in decision-making, and improving communication with patients. However, drawbacks and challenges such as limited AI capability, training on possibly biased data, data errors, security and privacy concerns, and implementation costs must be addressed to ensure the responsible and effective use of this technology. The future of LLMs in gastroenterology relies on the ability to process and analyse large amounts of data, identify patterns, and summarize information and thus assist physicians in creating personalized treatment plans. As AI advances, LLMs will become more accurate and efficient, allowing for faster diagnosis and treatment of gastroenterological conditions. Ensuring effective collaboration between AI developers, healthcare professionals, and regulatory bodies is essential for the responsible and effective use of this technology. By finding the right balance between AI and human expertise and addressing the limitations and risks associated with its use, LLMs can play an increasingly significant role in gastroenterology, contributing to better patient care and supporting doctors in their work.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24022784
003      
CZ-PrNML
005      
20250527094720.0
007      
ta
008      
241205s2024 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2024.027 $2 doi
035    __
$a (PubMed)39234774
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Král, Jan, $d 1985- $u Department of Internal Medicine, University Hospital Motol and Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0225291
245    10
$a Exploring the benefits and challenges of AI-driven large language models in gastroenterology: Think out of the box / $c J. Kral, M. Hradis, M. Buzga, L. Kunovsky
520    9_
$a Artificial Intelligence (AI) has evolved significantly over the past decades, from its early concepts in the 1950s to the present era of deep learning and natural language processing. Advanced large language models (LLMs), such as Chatbot Generative Pre-Trained Transformer (ChatGPT) is trained to generate human-like text responses. This technology has the potential to revolutionize various aspects of gastroenterology, including diagnosis, treatment, education, and decision-making support. The benefits of using LLMs in gastroenterology could include accelerating diagnosis and treatment, providing personalized care, enhancing education and training, assisting in decision-making, and improving communication with patients. However, drawbacks and challenges such as limited AI capability, training on possibly biased data, data errors, security and privacy concerns, and implementation costs must be addressed to ensure the responsible and effective use of this technology. The future of LLMs in gastroenterology relies on the ability to process and analyse large amounts of data, identify patterns, and summarize information and thus assist physicians in creating personalized treatment plans. As AI advances, LLMs will become more accurate and efficient, allowing for faster diagnosis and treatment of gastroenterological conditions. Ensuring effective collaboration between AI developers, healthcare professionals, and regulatory bodies is essential for the responsible and effective use of this technology. By finding the right balance between AI and human expertise and addressing the limitations and risks associated with its use, LLMs can play an increasingly significant role in gastroenterology, contributing to better patient care and supporting doctors in their work.
650    _2
$a lidé $7 D006801
650    12
$a gastroenterologie $7 D005762
650    12
$a umělá inteligence $7 D001185
650    12
$a zpracování přirozeného jazyka $7 D009323
650    _2
$a deep learning $7 D000077321
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Hradiš, Michal, $u MAIA LABS s.r.o., Brno, Czech Republic $u Faculty of Information Technology, University of Technology, Brno, Czech Republic $d 1983- $7 xx0332025
700    1_
$a Bužga, Marek $u Department of Physiology and Pathophysiology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic $7 mzk2005289941
700    1_
$a Kunovský, Lumír, $d 1984- $u 2nd Department of Internal Medicine - Gastroenterology and Geriatrics, University Hospital Olomouc and Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $u Department of Surgery, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Department of Gastroenterology and Digestive Endoscopy, Masaryk Memorial Cancer Institute, Brno, Czech Republic $7 xx0229136
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 168, č. 4 (2024), s. 277-283
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39234774 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20241205 $b ABA008
991    __
$a 20250527094720 $b ABA008
999    __
$a ok $b bmc $g 2324809 $s 1234789
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 168 $c 4 $d 277-283 $e 20240904 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $n Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub $x MED00012606
LZP    __
$b NLK124 $a Pubmed-20241205

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...